Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2011, Article ID 309068, 6 pages
http://dx.doi.org/10.1155/2011/309068
Clinical Study

Improvement of Hypertension after Parathyroidectomy of Patients Suffering from Primary Hyperparathyroidism

1Third Department of Medicine, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
2Third Department of Surgery, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
3Department of Nuclear Medicine, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic

Received 29 September 2010; Revised 19 December 2010; Accepted 4 January 2011

Academic Editor: Daniela Jezova

Copyright © 2011 P. D. Broulik et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [30 citations]

The following is the list of published articles that have cited the current article.

  • Ronald Pyram, Geeti Mahajan, and Agnieszka Gliwa, “Primary hyperparathyroidism: Skeletal and non-skeletal effects, diagnosis and management,” Maturitas, vol. 70, no. 3, pp. 246–255, 2011. View at Publisher · View at Google Scholar
  • Helmut Schiffl, and Susanne M. Lang, “Parathyroid hypertension: A rare, but curable form of secondary hypertension,” Current Hypertension Reviews, vol. 7, no. 3, pp. 200–205, 2011. View at Publisher · View at Google Scholar
  • John W. Kunstman, and Robert Udelsman, “Superiority of Minimally Invasive Parathyroidectomy,” Advances in Surgery, vol. 46, no. 1, pp. 171–189, 2012. View at Publisher · View at Google Scholar
  • Xiao-Gang Liu, Nan Miao, Man-Shu Sui, Su-Hong Mu, Shi-Lei Zhao, and Ru-Juan Xie, “Atorvastatin attenuates parathyroid hormone1-34 induced cardiomyocytes hypertrophy through downregulating K-Ras-ERK1/2 pathway,” Chinese Journal of Cardiology, vol. 40, no. 12, pp. 1051–1055, 2012. View at Publisher · View at Google Scholar
  • Petramala Luigi, Formicuccia Maria Chiara, Zinnamosca Laura, Marinelli Cristiano, Cilenti Giuseppina, Colangelo Luciano, Panzironi Giuseppe, Cerci Sabrina, Sciomer Susanna, Ciardi Antonio, Cavallaro Giuseppe, De Toma Giorgio, and Letizia Claudio, “Arterial Hypertension, Metabolic Syndrome and Subclinical Cardiovascular Organ Damage in Patients with Asymptomatic Primary Hyperparathyroidism before and after Parathyroidectomy: Preliminary Results,” International Journal of Endocrinology, vol. 2012, pp. 1–10, 2012. View at Publisher · View at Google Scholar
  • Zeina Habib, Adam Kabaker, and Pauline Camacho, “Sporadic primary hyperparathyroidism: medical and surgical updates,” Expert Review of Endocrinology & Metabolism, pp. 1–14, 2013. View at Publisher · View at Google Scholar
  • Shu-ichi Fujita, Yusuke Okamoto, Kensaku Shibata, Hideaki Morita, Takahide Ito, Koichi Sohmiya, Masaaki Hoshiga, and Nobukazu Ishizaka, “Serum Uric Acid Is Associated with Left Ventricular Hypertrophy Independent of Serum Parathyroid Hormone in Male Cardiac Patients,” Plos One, vol. 8, no. 12, 2013. View at Publisher · View at Google Scholar
  • Eleanor D. Ledererpp. 515–531, 2013. View at Publisher · View at Google Scholar
  • Leyla Mateus-Hamdan, Olivier Beauchet, Beatrice Bouvard, Bruno Fantino, Cedric Annweiler, and Erick Legrand, “High parathyroid hormone, but not low vitamin D concentrations, expose elderly inpatients to hypertension,” Geriatrics & Gerontology International, vol. 13, no. 3, pp. 783–791, 2013. View at Publisher · View at Google Scholar
  • Antonia García-Martín, Rebeca Reyes-García, José Miguel García-Castro, Miguel Quesada-Charneco, Fernando Escobar-Jiménez, and Manuel Muñoz-Torres, “Factores de riesgo cardiovascular en pacientes con hiperparatiroidismo primario asintomático,” Endocrinología y Nutrición, 2014. View at Publisher · View at Google Scholar
  • Kimon Stamatelopoulos, Fani Athanasouli, Theodora Pappa, Irene Labrinoudaki, Christos Papamichael, Antonis Polymeris, Georgios Georgiopoulos, Anastasia Vemmou, Leda Sarika, Evangelos Terpos, and Maria Alevizaki, “Hemodynamic Markers and Subclinical Atherosclerosis in Postmenopausal Women With Primary Hyperparathyroidism,” Journal of Clinical Endocrinology & Metabolism, vol. 99, no. 8, pp. 2704–2711, 2014. View at Publisher · View at Google Scholar
  • Emil Hagstrom, Karl Michaelsson, Hakan Melhus, Thomas Hansen, Hakan Ahlstrom, Lars Johansson, Erik Ingelsson, Johan Sundstrom, Lars Lind, and Johan Arnlov, “Plasma-Parathyroid Hormone Is Associated With Subclinical and Clinical Atherosclerotic Disease in 2 Community-Based Cohorts,” Arteriosclerosis Thrombosis and Vascular Biology, vol. 34, no. 7, pp. 1567–+, 2014. View at Publisher · View at Google Scholar
  • K. Chau, D. Holmes, A. Melck, and C. Chan-Yan, “Secondary Hypertension Due To Concomitant Aldosterone-Producing Adenoma and Parathyroid Adenoma,” American Journal of Hypertension, 2014. View at Publisher · View at Google Scholar
  • Emil Hagström, Tommy Ahlström, Johan Ärnlöv, Anders Larsson, Håkan Melhus, Per Hellman, and Lars Lind, “Parathyroid hormone and calcium are independently associated with subclinical vascular disease in a community-based cohort,” Atherosclerosis, 2014. View at Publisher · View at Google Scholar
  • Antonia García-Martín, Rebeca Reyes-García, José Miguel García-Castro, Miguel Quesada-Charneco, Fernando Escobar-Jiménez, and Manuel Muñoz-Torres, “Cardiovascular risk factors in patients with asymptomatic primary hyperparathyroidism,” Endocrinología y Nutrición (English Edition), 2014. View at Publisher · View at Google Scholar
  • Alok Kumar, and Sunita Singh, “Parathyroidectomy ameliorates glucose and blood pressure control in a patient with primary hyperparathyroidism, type 2 diabetes, and hypertension,” Clinical Medicine Insights: Endocrinology and Diabetes, vol. 8, pp. 63–66, 2015. View at Publisher · View at Google Scholar
  • Petr Broulík, Svatopluk Adámek, Petr Libánský, and Jozef Kubinyi, “Changes in the Pattern of Primary Hyperparathyroidism in Czech Republic,” Prague Medical Report, vol. 116, no. 2, pp. 112–121, 2015. View at Publisher · View at Google Scholar
  • Dwight A. Towler, “Physiological Actions of PTH and PTHrP IV,” The Parathyroids, pp. 187–201, 2015. View at Publisher · View at Google Scholar
  • Joseph M. Pappachan, and Harit N. Buch, “Endocrine Hypertension: A Practical Approach,” 2016. View at Publisher · View at Google Scholar
  • Mirko V. Lakicevic, Milan D. Jovanovic, Aleksandar D. Diklic, Nevena K. Kalezic, Vladan R. Zivaljevic, Anka R. Toskovic, Marina M. Stojanovic, Vera D. Sabljak, Biljana R. Milicic, Ivan R. Paunovic, Ksenija S. Stevanovic, Katarina M. Tausanovic, and Dejan Z. Markovic, “Risk Factors for Intraoperative Hypertension during Surgery for Primary Hyperparathyroidism,” Medical Principles and Practice, vol. 26, no. 4, pp. 381–386, 2017. View at Publisher · View at Google Scholar
  • Julia Wetzel, Stefan Pilz, Martin R. Grübler, Astrid Fahrleitner-Pammer, Hans P. Dimai, Dirk von Lewinski, Ewald Kolesnik, Sabine Perl, Christian Trummer, Verena Schwetz, Andreas Meinitzer, Evgeny Belyavskiy, Jakob Völkl, Cristiana Catena, Vincent Brandenburg, Winfried März, Burkert Pieske, Helmut Brussee, Andreas Tomaschitz, and Nicolas D. Verheyen, “Plasma parathyroid hormone and cardiovascular disease in treatment-naive patients with primary hyperparathyroidism: The EPATH trial,” The Journal of Clinical Hypertension, 2017. View at Publisher · View at Google Scholar
  • Jun Yang, Jimmy Shen, and Peter J. Fuller, “Diagnosing endocrine hypertension: a practical approach,” Nephrology, vol. 22, no. 9, pp. 663–677, 2017. View at Publisher · View at Google Scholar
  • Ferit Akgül, Alper Serçelik, Hakan Çetin, and Turgay Erten, “Association of parathyroid hormone and vitamin D with untreated hypertension: Is it different in white-coat or sustained hypertension?,” PLoS ONE, vol. 12, no. 11, 2017. View at Publisher · View at Google Scholar
  • Libansky, Adamek, Broulik, Fialova, Kubinyi, Sedy, Pafko, Yershov, and Lischke, “Measurement of intact parathormone during operation for primary hyperparathyroidism,” Bratislava Medical Journal, vol. 118, no. 5, pp. 255–257, 2017. View at Publisher · View at Google Scholar
  • Tej Purewal, Esmee Irvine, and Yew Wen Yap, “A case of acute confusion: Cushing's syndrome presenting with primary hyperparathyroidism,” BMJ Case Reports, vol. 2017, 2017. View at Publisher · View at Google Scholar
  • Kaela E Parnell, and Sarah C Oltmann, “The surgical management of primary hyperparathyroidism: an updated review,” International Journal of Endocrine Oncology, 2018. View at Publisher · View at Google Scholar
  • Andrew Collier, Sujoy Ghosh, Sian Nowell, and David Clark, “Increased Mortality In Patients With Primary Hyperparathyroidism: Does Surgery Make A Difference?,” Endocrine Practice, vol. 25, no. 4, pp. 335–339, 2019. View at Publisher · View at Google Scholar
  • Henriette Ejlsmark-Svensson, Lars Rolighed, and Lars Rejnmark, “Effect of Parathyroidectomy on Cardiovascular Risk Factors in Primary Hyperparathyroidism: A Randomized Clinical Trial,” The Journal of Clinical Endocrinology & Metabolism, vol. 104, no. 8, pp. 3223–3232, 2019. View at Publisher · View at Google Scholar
  • Ben Ponvilawan, Nipith Charoenngam, and Patompong Ungprasert, “Primary hyperparathyroidism is associated with a higher level of serum uric acid: A systematic review and meta‐analysis,” International Journal of Rheumatic Diseases, 2019. View at Publisher · View at Google Scholar
  • Sasan Mirfakhraee, and Dwight A. Towler, “Cardiovascular actions of parathyroid hormone/parathyroid hormone–related protein signaling,” Principles of Bone Biology, pp. 623–644, 2020. View at Publisher · View at Google Scholar